MENU
FULC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Fulcrum Therapeutics (FULC) Earnings Date & Reports
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases... Show more
A.I. Advisor
published Earnings
FULC is expected to report earnings to fall 7.76% to -23 cents per share on August 05
Q2'26
Est.
$-0.23
Q1'26
Beat
by $0.05
Q4'25
Est.
$-0.31
Q3'25
Missed
by $0.02
Q2'25
Beat
by $0.01
The last earnings report on April 27 showed earnings per share of -25 cents, beating the estimate of -30 cents. With 2.81M shares outstanding, the current market capitalization sits at 256.54M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies.
Industry Biotechnology
Profile
Details
Industry
N/A
Address
26 Landsdowne Street
Phone
+1 617 651-8851
Employees
55
Web
https://www.fulcrumtx.com